Origin Agritech Receives a $35 Million Order from Muyuan Foods
Companies Plan to Expand Partnership Significantly Beyond This Initial Order BEIJING, July 27, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that the company has received an order for its hybrid corn worth RMB240 million, or roughly $35 million, from Muyuan Foods. Muyuan Foods is a publicly traded company on the...
Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis
SHANGHAI, China, July 27, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnovator is committed to being a collaborative platform for Innovative Biotech companies from around the world. Over the past 2 month, its portfolio companies have had great progress. AIxplorerBIO and the Institute of Immunology at Tsinghua University Reached a Strategic Collaboration Agreement to Explore and...
BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging
Telix and BAMF Health use Illuccix® (kit for the preparation of Gallium Ga 68 gozetotide injection) for the first time with uEXPLORER® total-body PET scanner for prostate cancer imaging GRAND RAPIDS, Mich. and INDIANAPOLIS, July 27, 2022 /PRNewswire/ -- The PSMA-PET imaging agent Illuccix® from Telix Pharmaceuticals Limited (Telix) has been used...
NCCN Publishes New Patient Guidelines for Breast Cancer Screening and Diagnosis Emphasizing Annual Mammograms for All Average-Risk Women Over 40
The free evidence-based, expert consensus resource, available at NCCN.org/patientguidelines, helps people ask the right questions about when and how often to screen. PLYMOUTH MEETING, Pa., July 27, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Guidelines for Patients®: Breast Cancer Screening and Diagnosis to help people understand their...
Noul’s Hydrogel Stamping is the potential core technology necessary for precise cancer diagnosis, study confirmed
The method shows highly efficient and simple on immunostaining Research Paper by Biotech Start up Noul, Harvard Medical School, and Massachusetts General Hospital Published on American Chemical Society Applied Materials and Interfaces. YONGIN, South Korea, July 27, 2022 /PRNewswire/ -- A new study by Noul Co., Ltd., (376930.KR), a KOSDAQ-listed biotech...
Samsung Biologics Reports Second Quarter 2022 Financial Results
Released consolidated financial position of the company based on its full acquisition of Samsung Bioepis completed on April 20, 2022 Achieved record-high semi-annual revenue exceeding KRW 1 trillion Recorded Q2'22 revenue of KRW 503.7 billion for the company's CDMO business Recorded Q2'22 revenue of KRW 232.8 billion for Samsung Bioepis's biosimilars business Business operations remain stable with expanded...
Bushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific and Offering Customer Value with Its Advanced Gateway to Asia Services
The Gateway to Asia initiative ensures quality and timely delivery through shorter lead times, temperature and humidity control, and streamlined urgent order processing SAN ANTONIO, July 27, 2022 /PRNewswire/ -- Based on its recent analysis of the pharmaceutical supply chain contract services industry, Frost & Sullivan recognizes Bushu Pharma with the 2022 Japan...
2 in 3 Older Adults Do Not Consult a Regular Family Doctor, New Study Finds
New research unveiled by SMU's Centre for Research on Successful Ageing (ROSA) shows that only 35% of older adults in Singapore have a regular family doctor Having a regular family doctor ensures 'continuity of care' and is key to preventive health, as well as to identifying and addressing health conditions early Study recommends for more efforts...
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants
Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously demonstrated with all variants of concern to date The amubarvimab/romlusevimab combination is commercially available in China and is under review for Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) DURHAM, N.C....
EDAN Launches Next-Gen ABG Solutions for the Clinic During 2022 AACC
A lightweight POC CO-oximetry blood gas and chemistry system i20 reveals how photoluminescence biosensor coupled with microfluidics could transform the future of ABG tests in clinical departments. CHICAGO, July 26, 2022 /PRNewswire/ -- EDAN Instruments, Inc. (300206.SZ) announce the official launch of the first-of-its-kind POC (Point-of-Care) fluorescence-based CO-OX blood gas and chemistry analysis system, i20, equipped with over...
